Are the Cardiorenal Benefits of SGLT2 Inhibitors Due to Inhibition of the Sympathetic Nervous System?
Subodh Verma
Topics & Concepts
Sympathetic nervous systemCardiorenal syndromeMedicineHeart failureAutonomic nervous systemInternal medicineCardiologyPharmacologyHeart rateBlood pressureDiabetes Treatment and ManagementReceptor Mechanisms and SignalingPharmacology and Obesity Treatment